Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions

This article summarizes the current literature and documents new evidence concerning drug-drug interactions (DDI) stemming from pharmacogenomic and circadian rhythm determinants of therapies used to treat common cardiovascular diseases (CVD), such as atherosclerosis and hypertension. Patients with C...

Full description

Bibliographic Details

Published in:	Current Research in Pharmacology and Drug Discovery
Main Authors:	Yong-Jian Geng, Rosalinda Madonna, Ramon C. Hermida, Michael H. Smolensky
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Subjects:	Cardiovascular disease Drug Interactome Polypharmacy Pharmacogenomics Atherosclerosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590257121000122